Earlier this year, Materialise, a global supplier of 3D printing software and services, acquired FEops, a Belgian company that develops AI-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions.
The acquisition will allow Materialise to expand its cardiovascular solutions with predictive simulation capabilities, advancing the personalized treatment of patients with heart diseases. Increased mass personalization, enabled by 3D technologies, is enhancing healthcare by enabling tailored treatment plans and interventions that cater to the unique anatomy of individual patients, resulting in improved outcomes and patient satisfaction.
FEops combines predictive simulation technology and artificial intelligence, allowing clinicians to more accurately predict how transcatheter structural heart devices will interact with a patient’s anatomy. Materialise’s Mimics Planner for Structural Heart Interventions, an industry-standard solution for segmentation and anatomical analysis, planning, and design, enables the creation of accurate virtual 3D models based on medical image data.
With the integration of FEops, the Mimics Planner will offer a comprehensive solution for anatomy-based 3D planning and AI-based simulation, allowing clinicians to simulate the interaction between a medical device, such as a heart valve, and a patient’s unique anatomy. This advancement is set to transform patient care for structural heart diseases by offering a more interactive and AI-based solution for preparing heart procedures.
For more information, please visit www.materialise.com.
December 11, 2023 
